Known targets — ChEMBL curated mechanism
ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRA2A known ✓ | P08913 | 2/20 | 0.45 |
| ▸ | ADRA2B known ✓ | P18089 | 2/20 | 0.45 |
| ▸ | ADRA2C known ✓ | P18825 | 2/20 | 0.45 |
| ▸ | HDAC3 known ✓ | O15379 | 1/20 | 0.42 |
| ▸ | HDAC4 known ✓ | P56524 | 1/20 | 0.42 |
| ▸ | HDAC1 known ✓ | Q13547 | 1/20 | 0.42 |
| ▸ | HDAC7 known ✓ | Q8WUI4 | 1/20 | 0.42 |
| ▸ | HDAC2 known ✓ | Q92769 | 1/20 | 0.42 |
| ▸ | HDAC10 known ✓ | Q969S8 | 1/20 | 0.42 |
| ▸ | HDAC11 known ✓ | Q96DB2 | 1/20 | 0.42 |
| ▸ | HDAC8 known ✓ | Q9BY41 | 1/20 | 0.42 |
| ▸ | HDAC6 known ✓ | Q9UBN7 | 1/20 | 0.42 |
| ▸ | HDAC9 known ✓ | Q9UKV0 | 1/20 | 0.42 |
| ▸ | HDAC5 known ✓ | Q9UQL6 | 1/20 | 0.42 |
| ▸ | GAA known ✓ | P10253 | 1/20 | 0.41 |
| ▸ | CES2 | O00748 | 1/20 | 0.52 |
| ▸ | CES1 | P23141 | 1/20 | 0.52 |
| ▸ | LMNA | P02545 | 2/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.50 |
| ▸ | NAPRT | Q6XQN6 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL29535473 | 1.00 | CES2 (0.52) | CES2CES1LMNAL3MBTL1NAPRT | |
| Hydrochloric Acid SCHEMBL5945629 | 0.98 | CES2 (0.50) | CES2CES1LMNAL3MBTL1NAPRT | |
| SCHEMBL247847 | 0.98 | — | — | |
| Water SCHEMBL27552684 | 0.95 | CES2 (0.52) | CES2CES1LMNAL3MBTL1NAPRT | |
| Pyridine SCHEMBL30058515 | 0.90 | LMNA (0.50) | CES2CES1LMNAL3MBTL1NAPRT | |
| Pyrrole SCHEMBL28132369 | 0.86 | CES2 (0.44) | CES2CES1LMNAL3MBTL1NAPRT | |
| Acetic Acid SCHEMBL27680883 | 0.86 | ALDH1A1 (0.60) | CES2CES1LMNAL3MBTL1NAPRT | |
| Hydrochloric Acid SCHEMBL8545563 | 0.84 | GRM5 (0.43) | CES2CES1LMNAL3MBTL1NAPRT | |
| Ether SCHEMBL9739851 | 0.83 | ADRA2A (0.44) | CES2CES1LMNAL3MBTL1NAPRT | |
| Maleic Acid SCHEMBL7226173 | 0.83 | LMNA (0.53) | CES2CES1LMNAL3MBTL1NAPRT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 568 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119156093-A | Perovskite solar cell and preparation method thereof | 深圳职业技术大学 | 2024-12-17 | — | — | CN | claimed |
| CN-117998878-A | Passivation layer modified trans-perovskite solar cell and preparation method thereof | 深圳市曼恩斯特科技股份有限公司 | 2024-05-07 | — | — | CN | claimed |
| EP-3556803-B1 | CURING AGENTS FOR COMPOUNDS | DUPONT POLYMERS INC (US) | 2023-10-04 | — | — | EP | claimed |
| CN-113024470-B | 4-perfluoroalkyl substituted pyrimidine compound and preparation method and application thereof | 南京工业大学 | 2022-05-24 | — | — | CN | claimed |
| EP-3558964-B1 | 4-AMINO-2-PYRIDO-BICYCLIC PYRIMIDINES AND USE THEREOF AS TOPOISOMERASE II INHIBITORS | FONDAZIONE ST ITALIANO TECNOLOGIA (IT) | 2022-05-04 | — | — | EP | claimed |
| US-11274189-B2 | Curing agents for compounds | DUPONT POLYMERS, INC. (US) | 2022-03-15 | — | — | US | claimed |
| CN-113024470-A | 4-perfluoroalkyl substituted pyrimidine compound and preparation method and application thereof | 南京工业大学 | 2021-06-25 | — | — | CN | claimed |
| CN-110368782-A | A method of ammonia is efficiently trapped using H-bonding self-assembly type ionic liquid | 华侨大学 | 2019-10-25 | — | — | CN | claimed |
| EP-3556803-A1 | CURING AGENTS FOR COMPOUNDS | E. I. du Pont de Nemours and Company (US) | 2019-10-23 | — | — | EP | claimed |
| US-20190315709-A1 | 4-AMINO-2-PYRIDO-BICYCLIC PYRIMIDINES AND USE THEREOF AS TOPOISOMERASE II INHIBITORS | FONDAZIONE ISTITUTO ITALIANO DI TECNOLOGIA (IT) | 2019-10-17 | — | — | US | claimed |
| EP-3205690-A1 | CURING AGENTS FOR FLUOROELASTOMERS | E. I. du Pont de Nemours and Company (US) | 2017-08-16 | — | — | EP | claimed |
| US-20170088693-A1 | Curing Agents For Fluoroelastomers | DUPONT SPECIALTY PRODUCTS USA, LLC | 2017-03-30 | — | — | US | claimed |
| US-20170088692-A1 | CURING AGENTS FOR COMPOUNDS | E I DU PONT DE NEMOURS AND COMPANY (US) | 2017-03-30 | — | — | US | claimed |
| CN-106397433-A | 2-(2-pyridine)-6-(2-chloro-3-trifluoromethylbenzoyl)-5,7,8-trihydropyrido [4,3-d] pyrimidine and preparation method thereof | 广东环境保护工程职业学院 | 2017-02-15 | — | — | CN | claimed |
| CN-105669672-A | Pyridopyrimidine compounds and preparation method thereof | 广东环境保护工程职业学院 | 2016-06-15 | — | — | CN | claimed |
| EP-0670836-B1 | PYRIDYL-1,2,4-THIADIAZOLES AS PEST-CONTROL AGENTS | BAYER AG (DE) | 2001-10-04 | — | — | EP | claimed |
| EP-0557860-B1 | Substituted pyridiylpyrimidines and their use as parasiticide | BAYER AG (DE) | 2001-01-10 | — | — | EP | claimed |
| EP-0670836-A1 | PYRIDYL-1,2,4-THIADIAZOLES AS PEST-CONTROL AGENTS | BAYER AG (DE) | 1995-09-13 | — | — | EP | claimed |
| WO-1994012496-A1 | PYRIDYL-1,2,4-THIADIAZOLES AS PEST-CONTROL AGENTS | BAYER AKTIENGESELLSCHAFT (DE) | 1994-06-09 | — | — | WO | claimed |
| EP-0557860-A1 | Substituted pyridiylpyrimidines and their use as parasiticide | BAYER AG (DE) | 1993-09-01 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190315709-A1 | 4-AMINO-2-PYRIDO-BICYCLIC PYRIMIDINES AND USE THEREOF AS TOPOISOMERASE II INHIBITORS | TYMP, TOP2A, TOP2B | ADRA2A 2221/4885ADRA2B 1860/4885ADRA2C 1356/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.